Literature DB >> 7847071

A comparison of perineurial and vascular basal laminal changes in diabetic neuropathy.

J L Bradley1, P K Thomas, R H King, P J Watkins.   

Abstract

Measurements were made of the thickness of the basal lamina of perineurial cells in the sural nerve in a series of patients with diabetic neuropathy and compared with a group of patients with type I hereditary motor and sensory neuropathy (HMSN) and with organ donor control cases. The thickness was significantly greater in the diabetic patients as compared both with the HMSN cases and the organ donor controls. This was most obvious for the intermediate layers of the perineurium. Perineurial basal laminal thickness was only slightly greater in the HMSN cases than in the organ donor controls and the difference was not statistically significant. The thickening of the perineurial cell basal laminae was compared with the thickening of the basal laminal zone around the endoneurial microvessels. No significant correlation was found either for the diabetic neuropathy or HMSN cases or for the organ donor controls. As had been observed previously, the basal laminal zone around the endoneurial capillaries was of increased thickness both in the diabetic neuropathy and the HMSN cases and, although it was greater for the diabetic neuropathy patients, the difference was not statistically significant. Taken together, these findings indicate that the thickening of the basal lamina of the perineurial cells is a more characteristic feature of diabetic neuropathy than is thickening of the basal laminal zone around the endoneurial capillaries. The results suggest that the causative mechanisms are likely to differ, a conclusion supported by the morphological appearances: the basal laminal thickening around the perineurial cells is uniform, whereas that around the capillaries consists of basal laminal reduplication.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7847071     DOI: 10.1007/bf00389494

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  The cellular response to nerve injury. II. Regeneration of the perineurium after nerve section.

Authors:  P K Thomas; D G Jones
Journal:  J Anat       Date:  1967-01       Impact factor: 2.610

2.  The use of PIPES buffer in the fixation of mammalian and marine tissues for electron microscopy.

Authors:  P S Baur; T R Stacey
Journal:  J Microsc       Date:  1977-04       Impact factor: 1.758

3.  Basic two-dye stains for epoxy-embedded 0.3-1 sections.

Authors:  J Sievers
Journal:  Stain Technol       Date:  1971-07

4.  Abnormal binding of negatively charged serum proteins to diabetic basement membranes is largely a systemic phenomenon.

Authors:  V Murrah; J Crosson; J Sauk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  Effects of streptozotocin diabetes, glucose, and insulin on the metabolism of type IV collagen and proteoglycan in murine basement membrane-forming EHS tumor tissue.

Authors:  T Pihlajaniemi; R Myllylä; K I Kivirikko; K Tryggvason
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

6.  Significance of degenerating endoneurial cells in peripheral neuropathy.

Authors:  H Grehl; J M Schröder
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Glomerular basement membrane metabolism in the diabetic rat. In vivo studies.

Authors:  M Brownlee; R G Spiro
Journal:  Diabetes       Date:  1979-02       Impact factor: 9.461

8.  Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology.

Authors:  R J Guy; J L Dawson; J R Garrett; J W Laws; P K Thomas; A K Sharma; P J Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

9.  Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy.

Authors:  R H King; J G Llewelyn; P K Thomas; S G Gilbey; P J Watkins
Journal:  Neuropathol Appl Neurobiol       Date:  1989 Jul-Aug       Impact factor: 8.090

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  7 in total

Review 1.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

2.  A quantitative analysis of perineurial cell basement membrane collagen IV, laminin and fibronectin in diabetic and non-diabetic human sural nerve.

Authors:  R E Hill; R E Williams
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

3.  Extracellular matrix remodelling in human diabetic neuropathy.

Authors:  Rebecca Hill
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

4.  Development of an instrument for measurement of light scattering at the corneal epithelial basement membrane in diabetic patients.

Authors:  Norihisa Takahashi; Makiko Wakuta; Naoyuki Morishige; Tai-ichiro Chikama; Teruo Nishida; Yasuhiro Sumii
Journal:  Jpn J Ophthalmol       Date:  2007-06-07       Impact factor: 2.447

5.  Morphometric analysis of connective tissue sheaths of sural nerve in diabetic and nondiabetic patients.

Authors:  Braca Kundalić; Slađana Ugrenović; Ivan Jovanović; Natalija Stefanović; Vladimir Petrović; Jasen Kundalić; Vesna Stojanović; Vladimir Živković; Vladimir Antić
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

6.  Epithelial changes with corneal punctate epitheliopathy in type 2 diabetes mellitus and their correlation with time to healing.

Authors:  Jing-Hao Qu; Li Li; Lei Tian; Xiao-Yu Zhang; Ravi Thomas; Xu-Guang Sun
Journal:  BMC Ophthalmol       Date:  2018-01-04       Impact factor: 2.209

7.  Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.

Authors:  Beatriz Duran-Jimenez; Darin Dobler; Sarah Moffatt; Naila Rabbani; Charles H Streuli; Paul J Thornalley; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.